Blood cancers

Time burden of chemotherapy needs to be considered in decision making

Time spent commuting to and waiting for health care appointments is a significant contributor to the treatment burden in cancer patients with a shortened life expectancy. A US study assessing the opportunity costs of palliative chemotherapy in 362 patients with metastatic pancreatic ductal adenocarcinoma found just over 50% of total hours devoted to healthcare was ...

Already a member?

Login to keep reading.

© 2021 the limbic